OTCMKTS:MTHRF - M3 Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$80.50
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New M3 Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MTHRF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MTHRF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for M3 in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $80.50.
Buy
The current consensus among 3 contributing investment analysts is to buy stock in M3.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/12/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/10/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/9/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/8/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/6/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/4/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/3/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/3/2020

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
11/18/2020Credit Suisse GroupUpgradeNeutral ➝ Outperform
i
8/19/2020MizuhoUpgradeNeutral ➝ Buy
i
4/7/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight
i
(Data available from 12/3/2015 forward)
M3 logo
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates m3.com, a members-only Web site for providing information to the healthcare professionals; and MR-kun that delivers medical and drug information online through m3.com. It also provides MDLinx that offers the review of medical articles and theses in English for physicians in the United States; and MEDI:GATE, which provides various medical news and content, and features online discussion boards where doctors can exchange opinions and communicate with one another in South Korea. In addition, the company offers various Internet-based services for pharmaceutical and other medical-related companies, including marketing support services for medical solution providers and healthcare professionals, clinical trial services, clinical trial support services, market research services, and doctor and pharmacist recruiting support services. Further, it provides services for general public, such as the operation of AskDoctors, a Q and A site to consult doctors through the Internet; Ichie Websites comprising Ichie Breast Cancer and Ichie Menopause, which offers insights and solutions related to breast cancer and menopause; and iTicket Plus, a reservation system for clinics through mobile phones and the Internet. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was founded in 2000 and is headquartered in Tokyo, Japan.
Read More

Today's Range

Now: $80.50
$80.50
$80.50

50 Day Range

MA: $71.97
$66.84
$80.50

52 Week Range

Now: $80.50
$23.93
$80.50

Volume

N/A

Average Volume

1,474 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A